Adjuvant zoledronic acid for breast cancer: mechanism of action?

被引：10
|
作者：
Kunzmann, Volker [1 ,2 ]
Wilhelm, Martin [3 ]
机构：
[1] Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[3] Klinikum Nurnberg, Clin Med Oncol & Hematol, Nurnberg, Germany
来源：
LANCET ONCOLOGY | 2011年 / 12卷 / 11期
关键词：
IN-VIVO; THERAPY; WOMEN;
D O I：
10.1016/S1470-2045(11)70252-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：991 / 992
页数：4
相关论文
共 50 条
  • [31] Impact of MAF gene amplification on disease recurrence and effects of adjuvant zoledronic acid in early breast cancer
    Coleman, R.
    Hall, A.
    Bell, R.
    Cameron, D.
    Marshall, H.
    Jean-Mairet, J.
    Tercero, J.
    Rojo, F.
    Albanell, J.
    Gomis, R.
    CANCER RESEARCH, 2017, 77
  • [32] The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials
    Yan, Tingting
    Yin, Wenjin
    Zhou, Qiong
    Zhou, Liheng
    Jiang, Yiwei
    Du, Yueyao
    Shao, Zhimin
    Lu, Jinsong
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (02) : 187 - 195
  • [33] Should adjuvant zoledronic acid be used in early-stage, endocrine-sensitive breast cancer?
    Lamond, N. W. D.
    Skedgel, C.
    Rayson, D.
    Younis, T.
    CANCER RESEARCH, 2013, 73
  • [34] Zoledronic acid - a multiplicity of anti-cancer action
    Yuasa, Takeshi
    Kimura, Shinya
    Ashihara, Eishi
    Habuchi, Tomonori
    Maekawa, Taira
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (20) : 2126 - 2135
  • [35] Ibandronic acid safer than zoledronic acid in breast cancer
    Reactions Weekly, 2005, 1080 (1) : 5 - 5
  • [36] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [37] Zoledronic acid 'benefits women with early breast cancer'
    Gnant, Michael
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1615 - 1615
  • [38] Zoledronic acid combined with adjuvant tamoxifen with or without ovarian function suppression in premenopausal early breast cancer patients
    El-Ibrashi, M. M.
    El-Sadda, W. M.
    Abdel-Halim, I. I.
    Elashri, M. S.
    CANCER RESEARCH, 2016, 76
  • [39] Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer
    Brufsky, Adam
    Harker, W. Graydon
    Beck, J. Thaddeus
    Carroll, Robert
    Tan-Chiu, Elizabeth
    Seidler, Christopher
    Hohneker, John
    Lacerna, Leo
    Petrone, Stephanie
    Perez, Edith A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 829 - 836
  • [40] Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
    Vidula, Neelima
    Greenberg, Sally
    Petrillo, Laura
    Hwang, Jimmy
    Melisko, Michelle
    Goga, Andrei
    Moasser, Mark
    Magbanua, Mark
    Park, John W.
    Rugo, Hope S.
    NPJ BREAST CANCER, 2021, 7 (01)
12345